Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?

Page 1 of 2

Complete Genomics, Inc. (NASDAQ:GNOM)Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. GNOM investors should pay attention to an increase in activity from the world’s largest hedge funds lately. There were 7 hedge funds in our database with GNOM positions at the end of the previous quarter.

In the financial world, there are many metrics market participants can use to analyze their holdings. A couple of the most useful are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best investment managers can trounce the S&P 500 by a superb margin (see just how much).

Equally as integral, positive insider trading sentiment is another way to break down the world of equities. Obviously, there are a variety of stimuli for an insider to sell shares of his or her company, but just one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this tactic if investors know what to do (learn more here).

Now, it’s important to take a gander at the latest action surrounding Complete Genomics, Inc. (NASDAQ:GNOM).

How have hedgies been trading Complete Genomics, Inc. (NASDAQ:GNOM)?

At the end of the fourth quarter, a total of 9 of the hedge funds we track were long in this stock, a change of 29% from the third quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were increasing their stakes significantly.

When looking at the hedgies we track, Cliff Asness’s AQR Capital Management had the most valuable position in Complete Genomics, Inc. (NASDAQ:GNOM), worth close to $7.7 million, accounting for less than 0.1%% of its total 13F portfolio. Coming in second is Carl Tiedemann and Michael Tiedemann of TIG Advisors, with a $3.8 million position; 0.7% of its 13F portfolio is allocated to the company. Some other peers with similar optimism include Jean-Marie Eveillard’s First Eagle Investment Management, James Dondero’s Highland Capital Management and Kerr Neilson’s Platinum Asset Management.

As aggregate interest increased, some big names have jumped into Complete Genomics, Inc. (NASDAQ:GNOM) headfirst. TIG Advisors, managed by Carl Tiedemann and Michael Tiedemann, initiated the most outsized position in Complete Genomics, Inc. (NASDAQ:GNOM). TIG Advisors had 3.8 million invested in the company at the end of the quarter. Jean-Marie Eveillard’s First Eagle Investment Management also made a $3.6 million investment in the stock during the quarter. The following funds were also among the new GNOM investors: Israel Englander’s Millennium Management, Jacob Gottlieb’s Visium Asset Management, and D. E. Shaw’s D E Shaw.

Insider trading activity in Complete Genomics, Inc. (NASDAQ:GNOM)

Bullish insider trading is most useful when the primary stock in question has seen transactions within the past half-year. Over the latest half-year time period, Complete Genomics, Inc. (NASDAQ:GNOM) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Complete Genomics, Inc. (NASDAQ:GNOM). These stocks are Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Omeros Corporation (NASDAQ:OMER), Inovio Pharmaceuticals Inc (NYSEAMEX:INO), and BioSpecifics Technologies Corp. (NASDAQ:BSTC). This group of stocks are the members of the biotechnology industry and their market caps resemble GNOM’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!